The ad promotes an Epoch Health / The Epoch Times article titled “A Surprising Cause of Pancreatic Cancer” (also published as “Insulin Resistance Is Silent Driver of Pancreatic Cancer: Study”). The core claim is that excess insulin (hyperinsulinemia), often tied to insulin resistance, poor diet, obesity, and type 2 diabetes, can drive the initiation of pancreatic cancer.
Key Research Behind the Claim
This is based primarily on University of British Columbia (UBC) research led by James Johnson and Janel Kopp (with first author Anni Zhang and colleagues), published in Cell Metabolism (2023; earlier related work in 2019).
In mouse models with a common Kras mutation (found in most human pancreatic cancers) and diet-induced obesity/hyperinsulinemia:
- High insulin levels act directly on insulin receptors in pancreatic acinar cells (the cells that produce digestive enzymes).
- This overstimulates the cells, increasing production of digestive enzymes.
- Excess enzymes can activate inappropriately, causing local damage, inflammation, and conversion of acinar cells into precancerous lesions called pancreatic intraepithelial neoplasias (PanINs).
- Genetically reducing insulin production or removing insulin receptors specifically from acinar cells significantly reduced PanIN and tumor formation, without major effects on blood glucose control.
The researchers conclude that the elevated cancer risk linked to obesity and type 2 diabetes is at least partly driven by chronically high insulin, not just high blood sugar. They suggest that lowering insulin (via diet, exercise, weight loss, or certain medications) could help reduce risk.
A recent Daily Mail piece (August 2026) notes that the Epoch Times coverage of this work went viral, and the UBC team has indicated ongoing work suggesting excess insulin may also support tumor growth after initiation. Rates of pancreatic cancer have been rising, including among younger people, which has drawn attention to lifestyle factors like diet.
Context on Pancreatic Cancer Risk
Established risk factors include:
- Smoking
- Obesity (especially central)
- Chronic pancreatitis
- Long-standing or new-onset type 2 diabetes
- Heavy alcohol use
- Certain genetic syndromes
New-onset diabetes in older adults can sometimes be an early warning sign of an underlying pancreatic tumor. Insulin resistance and hyperinsulinemia fit into the broader metabolic picture that elevates risk.
Practical Notes from the Coverage
The Epoch Times article and related reporting emphasize lifestyle approaches that improve insulin sensitivity:
- Balanced diet focused on whole foods, fiber, and controlled portions (to limit blood sugar/insulin spikes)
- Regular exercise (including post-meal activity)
- Weight management
They also mention drugs like metformin (which improves insulin sensitivity) in the broader discussion of metabolic health and cancer risk. These are general strategies discussed in the coverage, not medical prescriptions.
Important caveats: This is primarily mouse model + mechanistic evidence supporting a causal role for hyperinsulinemia in initiation. Human epidemiology links obesity, diabetes, and high insulin to higher pancreatic cancer risk, but direct translation of the exact mechanism and prevention strategies requires further clinical research. Pancreatic cancer is aggressive and often diagnosed late; early detection remains challenging.
The screenshot shows a sponsored/promoted post from Epoch Health on X. The underlying science is from peer-reviewed UBC work rather than pure speculation, though media headlines (including Epoch’s) frame it as a “surprising” cause. For personal health concerns, consult a physician—especially regarding diabetes risk, family history, or symptoms.
